Everolimus Plus Letrozole for Treatment of Patients With HR+, HER2– Advanced Breast Cancer Progressing on Endocrine Therapy: An Open-label, Phase II Trial
- Resource Type
- Article
- Source
- In
Clinical Breast Cancer April 2018 18(2):e197-e203 - Subject
- Language
- ISSN
- 1526-8209